Disabled-2 Exerts Its Tumor Suppressor Activity by Uncoupling c-Fos Expression and MAP Kinase Activation
Open Access
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (29) , 26814-26818
- https://doi.org/10.1074/jbc.m101820200
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functionsMolecular Systems Biology, 2013
- ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometryOncogene, 1999
- Disabled-2 inactivation is an early step in ovarian tumorigenicityOncogene, 1999
- Regulation of Rat DOC-2 Gene during Castration-Induced Rat Ventral Prostate Degeneration and Its Growth Inhibitory Function in Human Prostatic Carcinoma CellsEndocrinology, 1998
- DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancerOncogene, 1998
- Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2Oncogene, 1998
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- Signal Transduction from the Extracellular Matrix. A Role for the Focal Adhesion Protein-tyrosine Kinase FAK.Cell Structure and Function, 1996
- Aberrant function of the Ras signal transduction pathway in human breast cancerBreast Cancer Research and Treatment, 1995
- Signal transduction—a conserved pathway from the membrane to the nucleusDevelopmental Genetics, 1993